LSL Web-Exclusive Content

11. Why Royalty Financing Is A Smart Funding Alternative For Small Life Science Companies 9/27/2023

    Royalty financing has emerged as an attractive solution to secure funding in the current challenging fundraising environment, offering a range of advantages tailored to the unique characteristics of small life science companies, from preserving ownership and intellectual property control to providing accessible funding for high-risk ventures.

12. How To Lose A Batch In 10 Days 9/25/2023

    Inspired by the rom com How to Lose a Guy in 10 Days, this article spotlights the critical missteps that could lead you to lose a batch during the manufacturing process. By identifying these pitfalls, the author guides you toward best practices that will not only save your batches but also improve the quality, efficiency, and reliability of your operations. 

13. 4 Pitfalls Of Poor-Performing Clinical Trial Teams — And How To Prevent Them 9/25/2023

    Sudden teammate departure? Unexpected shift in strategy? Learn about the four common pitfalls (related to communications and team expectations) of clinical operations teams — and how to avoid them — with these pointers from consultant Monica Roy.

14. Can DCTs Be Both Patient Centric And Financially Efficient For Sites? 9/22/2023

    While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.

15. Moderna Addresses Awareness Gap, Builds Community Trust To Boost CMV Trial Recruitment 9/20/2023

    Fewer than one in four Americans are aware of the leading cause of pediatric birth defects — a common and contagious viral infection known as cytomegalovirus, (CMV). Moderna aims to overcome this awareness gap and enroll patients in CMV trials using lessons learned from its COVID-19 clinical trials.

16. The Risks Of Trying To Emulate The 800-Pound Gorillas Of Business 9/19/2023

    It's important to remember that what works for behemoth companies may not necessarily align with the reality of smaller enterprises — especially when it comes to hiring.

17. Essential Elements Of Technology Transfer 9/19/2023

    The principles of an effective technology transfer can apply at every stage of the drug development lifecycle for biotech companies of every size. Tech transfer programs are usually bespoke, but they share common essential elements. This article breaks them down.

18. Navigating The Hype Of AI In Clinical Research 9/18/2023

    When you consider the rising cost of healthcare in America, a shortage amounting to tens of thousands of physicians, and economic headwinds stirring fear across the field, we can’t afford to not use AI. We shouldn’t be asking ourselves questions of why, but rather, why not. But that begs a new question: Why haven’t we seen the impact, adoption, and value of AI more broadly across clinical research?

19. Moving From Clinical Stage To Commercial? 4 Steps For An Outsourcing Strategy 9/18/2023

    If you're a pre-commercial bio/pharma looking ahead to commercial stage, evaluating partnerships are faced with making key decisions around which capabilities to outsource, the degree of data access and ownership, and which external partners are the right fit. Here are four key actions to consider.

20. Survey Results Show What Could Finally Make Sustainability Stick 9/8/2023

    Results from BioPlan's "20th Annual Report of Biopharmaceutical Manufacturing and Production" show that lasting sustainability strategies should focus on profitability aspects. That's because, even more than a spirit of stewardship, financial advantages provide a powerful incentive to stick to the plan.